Author:
Fender Anke C.,Dobrev Dobromir
Funder
National Institutes of Health
European Commission
Deutsche Forschungsgemeinschaft
Reference15 articles.
1. Nakano et al. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation, In this issue.
2. Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: a meta-analysis of 41,013 hospitalized patients;Ogungbe;Int. J. Cardiol. Heart Vasc.,2022
3. Thrombin-mediated direct activation of proteinase-activated Receptor-2: another Target for thrombin signaling;Mihara;Mol. Pharmacol.,2016
4. Redox regulation of human protease-activated receptor-2 by activated factor X;Jobi;Free Radic. Biol. Med.,2011
5. Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology;Dobrev;Nat. Rev. Cardiol.,2023